July 7, 2020 / 12:12 PM / a month ago

BRIEF-New Ntm Treatment Guidelines Recommend Insmed's Arikayce For Treatment Of Patients With Refractory Mac Lung Disease

July 7 (Reuters) - Insmed Inc:

* NEW NTM TREATMENT GUIDELINES RECOMMEND INSMED’S ARIKAYCE® (AMIKACIN LIPOSOME INHALATION SUSPENSION) FOR TREATMENT OF PATIENTS WITH REFRACTORY MAC LUNG DISEASE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below